Clinical Trial Update: Efficacy and Safety Dose Titration Study of Botulinum Toxin Type A to Treat Spasticity in the Leg and Arm [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating dose-titration of botulinum toxin type A for spasticity in the legs and arms due to cerebral causes. The study has completed and result…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cerebral Palsy
• Spasticity
• Stroke
• Traumatic Brain Injury

Drugs mentioned

• XEOMIN (INCOBOTULINUMTOXINA)

Snippet

Sponsor: Merz Pharmaceuticals GmbH | Conditions: Spasticity of the Upper and Lower Limb Due to Cerebral Causes | Phase 3 | Status: COMPLETED | Results posted: 2017-02-03